Paid Clinical Trials Lincoln
Discover 551 paid clinical trials in Lincoln, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Chyme Reinfusion for Type 2 Intestinal FailureChyme Reinfusion for Type 2 Intestinal Failure
Sponsor:
Databean
Location:
Code:
NCT04577456
Conditions
Intestinal Failure
Enterocutaneous Fistula
Ileostomy - Stoma
High Output Stoma
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Not accepted
Interventions
The Insides System
MPH HCl EREfficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years with ADHD
Sponsor:
Ironshore Pharmaceuticals and Development, Inc
Location:
Code:
NCT06431256
Conditions
Attention Deficit Hyperactivity Disorder
Eligibility Criteria
Sex: All
Age: 4 - 5
Healthy Volunteers: Not accepted
Interventions
HLD200 methylphenidate hydrochloride capsules
Placebo HLD200 capsules
ABBV-383A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma
Sponsor:
TeneoOne Inc.
Location:
Code:
NCT05650632
Conditions
Multiple Myeloma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ABBV-383
Observational StudyAn INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY to ASSESS the PERFORMANCE of the CORDIO HEARO SYSTEM
Sponsor:
Cordio Medical
Location:
Code:
NCT06378632
Conditions
Heart Failure
Eligibility Criteria
Sex: All
Age: 22+
Healthy Volunteers: Not accepted
Interventions
Hearo App
BHV-7000A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures
Sponsor:
Biohaven Therapeutics Ltd.
Location:
Code:
NCT06425159
Conditions
Generalized Epilepsy
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
BHV-7000
Placebo
Interested in new trials?
Get alerts for new trials in your area by subscribing now
VAX-31A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants
Sponsor:
Vaxcyte, Inc.
Location:
Code:
NCT06720038
Conditions
Pneumococcal Vaccines
Eligibility Criteria
Sex: All
Age: 42 - 70+
Healthy Volunteers: Accepted
Interventions
0.5 mL of the low dose VAX-31
0.5 mL of the mid dose VAX-31
0.5 mL of the high dose VAX-31
0.5 mL dose of PCV20
RemibrutinibA Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT05976243
Conditions
Chronic Inducible Urticaria
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Remibrutinib
Placebo
Observational StudyPatient-Defined Treatment Success and Preferences in Stage IV Lung Cancer Patients
Sponsor:
University of Nebraska
Location:
Code:
NCT02190864
Conditions
Particularly Rural/Urban Residence
Gender
Age
FACT-TOI Scores
Comorbid Conditions
Eligibility Criteria
Sex: All
Age: 19+
Healthy Volunteers: Not accepted
Porcine Membrane vs Bovine Wound DressingPorcine Membrane vs Bovine Wound Dressing in Human Tooth Extraction Sites
Sponsor:
University of Nebraska
Location:
Code:
NCT05802602
Conditions
Wound Heal
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Accepted
Interventions
Porcine Collagen Membrane
Bovine Collagen Dressing
LumateperoneSafety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With Autism Spectrum Disorder
Sponsor:
Intra-Cellular Therapies, Inc.
Location:
Code:
NCT06557902
Conditions
Autism Spectrum Disorder
Eligibility Criteria
Sex: All
Age: 5 - 12
Healthy Volunteers: Not accepted
Interventions
Lumateperone 10.5 mg capsule
Lumateperone 21 mg capsule
Lumateperone 5 mg ODT
Lumateperone 10.5 mg ODT
Lumateperone 15.5 mg ODT